Brief: Sonoma Pharmaceuticals Enters Into Exclusive Distribution Agreement With Daewoong Pharmaceutical Co
Jan 31 (Reuters) - Sonoma Pharmaceuticals Inc SNOA.O :
* SONOMA PHARMACEUTICALS - EFFECTIVE JANUARY 26, 2023, CO
ENTERED
INTO EXCLUSIVE DISTRIBUTION AGREEMENT WITH DAEWOONG
PHARMACEUTICAL CO
* SONOMA PHARMACEUTICALS - AGREEMENT FOR MARKETING AND
DISTRIBUTION OF PRIMOCYN(TM)SKIN SOLUTION PRODUCTS IN SOUTH
KOREA
* SONOMA PHARMACEUTICALS INC - AGREEMENT IS FOR AN INITIAL
TERM OF
TWO YEARS, SUBJECT TO AUTOMATIC TWO-YEAR RENEWAL PERIODS
Further company coverage: SNOA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Sonoma Pharmaceuticals
See all newsSonoma Pharmaceuticals Q1 revenue rises on US growth
Brief: Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million
Sonoma Pharmaceuticals Q4 revenue rises 48% on US growth
Brief: Sonoma Pharmaceuticals Q4 Net Income USD -600 Thousand
Brief: Sonoma Pharmaceuticals Inc - Offers Units In Public Offering For Gross Proceeds Of $5 Million - SEC Filing